Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
ReShape Lifesciences similar filings
- 30 Oct 19 ReShape Lifesciences Appoints Thomas Stankovich as Chief Financial Officer
- 24 Oct 19 Termination of a Material Definitive Agreement
- 30 Sep 19 Entry into a Material Definitive Agreement
- 11 Sep 19 Changes in Registrant's Certifying Accountant
- 6 Aug 19 Departure of Directors or Certain Officers
- 19 Jun 19 Entry into a Material Definitive Agreement
- 20 May 19 ReShape Lifesciences Announces First Quarter 2019 Financial Results
Filing view
External links
September 10, 2019
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549-7561
Dear Sirs/Madams:
We have read Item 4.01 of ReShape Lifesciences Inc.’s Form 8-K dated September 10, 2019, and we agree with the statements made therein.
Yours truly,
DELOITTE & TOUCHE LLP